Cytometry by Time of Fight (CyTOF) for High-speed Single-cell Analysis
Cytometry by Time of Fight (CyTOF) for High-speed Single-cell Analysis
批准号:
9075728
负责人:
Fei Wen
金额:
$60.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2017-03-31
关键词:
6 year oldAddressAdvisory CommitteesAntibodiesAreaAwardBioinformaticsBiologicalBiologyBiomedical EngineeringCancer BiologyCellsClinical ResearchComplexCytometryDetectionElementsEnsureEquipmentFundingGoalsHealthImmunologic MonitoringImmunologyLabelMass Spectrum AnalysisMetalsMichiganNeurologyPathologyPopulationResearchResearch ActivityResearch InfrastructureResearch PersonnelSchoolsSpeedSystemTechnologyTherapeuticTimeTrainingUnited States National Institutes of HealthUniversitiesbasebonecollegeexperiencefightingfundamental researchimprovedinstrumentoperationpre-clinicalprogramsranpirnaseresearch studysingle cell analysis
中文摘要
描述(由申请人提供):本提案的目的是申请600,000美元用于购买CyTOF,一种基于质谱的细胞仪,供密歇根大学的多名研究者使用。CyTOF是一项只有6年历史的尖端技术。在美国有大约50台CyTOF仪器,目前整个密歇根州都没有。CyTOF的关键特征是使用金属元素标记的抗体,能够检测单个细胞上多达100个标志物,而使用荧光标记抗体的流式细胞仪技术只有约12个参数。CyTOF的这种精致的多重检测能力能够在广度(一次检测许多细胞群体)和深度(检测每个群体上的许多标记物)上对复杂的生物/免疫系统进行更全面的评估。这种系统的方法对于促进我们对这些复杂系统的理解,扩展可以在多个研究方向上解决的问题,以及实现许多领域的基础和临床研究目标至关重要。因此,该提案支持来自密歇根大学4所学校和学院10个部门的24名研究人员,他们看到了使用CyTOF加速和推进其研究计划的巨大潜力。这24个专业用户签约了28个R 01、5个R21、4个R 03的85%的设备时间用于实验,P01的1个项目,P30的2个项目,U19的3个项目,NIH主任奖1个,U 54和R56奖2个,共47个NIH资助项目。这些项目与NIH改善健康的目标直接相关,包括癌症生物学和治疗学、病理学、骨生物学、免疫学、神经学、免疫生物工程等不同领域的研究。因此,该提案将明确支持密歇根大学NIH资助研究的基础设施,并代表了建立复杂细胞网络研究最先进设施的重要奋进。CyTOF将得到免疫监测核心(IMC)、经验丰富的技术人员(1.0 FTE)、生物信息学专家、内部咨询委员会和PI的支持,PI在CyTOF方面拥有丰富的研究和技术经验。一个吸引和培训新用户的系统已经到位,以确保其他NIH资助的研究人员可以使用。CyTOF的空间、购置(30,000美元)和长期运行(四年内每年总计119,500美元)得到了强有力的机构支持。IMC将建立一个用户驱动的充电系统,以持续长期使用CyTOF。总之,CyTOF在密歇根大学的可用性显然将对许多研究者(已经确定了24个)的基础,临床前和转化NIH资助的研究活动产生广泛的影响;我们有强大的基础设施,行政,财政,技术和数据支持,以建立一个成功和充满活力的CyTOF计划。
英文摘要
DESCRIPTION (provided by applicant): The objective of this proposal is to request $600,000 to purchase a CyTOF, a mass-spectrometry-based cytometer, for multi-investigator use at the University of Michigan. CyTOF is a cutting edge technology only ~6 years old. There are ~50 CyTOF instruments available in the US, and currently there is none available in the entire State of Michigan. The key feature of CyTOF is the use of metal element-tagged antibodies that enables detection of up to 100 markers on a single cell, as compared to ~12 parameters for the staple flow cytometery technology that uses fluorescently labeled antibodies. This exquisite multiplexed detection capability of the CyTOF enables a much more comprehensive assessment of complex biological/immunological systems with both breadth (detect many cell populations at once) and depth (detect many markers on each of the populations). This systematic approach is critical for advancing our understanding of these complex systems, for expanding the questions that can be addressed in multiple investigative directions, and for achieving fundamental and clinical research goals in many fields. As such, this proposal supports a group of 24 investigators from 10 Departments in 4 Schools and Colleges at the University of Michigan, who see the great potential of the use of CyTOF in accelerating and advancing their research programs. These 24 majors users have signed up for 85% of the equipment time for experiments in 28 R01s, 5 R21s, 4 R03s, one project in P01, two projects in P30, three projects in U19, one NIH Director's Award, one U54 and two R56 awards, a total of 47 NIH-funded projects. These projects are directly related to NIH goals of improving health and include studies in diverse areas of cancer biology and therapeutics, pathology, bone biology, immunology, neurology, immuno-bioengineering, etc. Thus, this proposal will clearly support the infrastructure of NIH-funded research at the University of Michigan, and represent an important endeavor to establish the state-of-the-art facility for complex cellular network studies. The CyTOF will be supported by the Immunologic Monitoring Core (IMC), experienced technical staff (1.0 FTE), bioinformatics experts, an Internal Advisory Committee, and the PI, who has extensive research and technical experience with the CyTOF. A system to attract and train new users is in place to ensure accessibility to other NIH-funded investigators. Strong institutional supports have been committed to the space, acquisition ($30,000), and long-term operation (a total of $119,500 per year for a period of four years) of the CyTOF. A user-driven recharge system will be set up by the IMC for the continued long-term use of the CyTOF. In summary, availability of the CyTOF at the University of Michigan will clearly have a broad impact on the basic, preclinical, and translational NIH-funded research activities of many investigators (24 already identified); and we have strong infrastructural, administrative, fiscal, technical, and dat supports for establishing a successful and vibrant CyTOF program.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Deciphering T cell repertoire using DNA-barcoded MHC-peptide tetramers
-
批准号:8622232
-
项目类别:
-
资助金额:$7.06万
-
财政年份:2014
-
负责人:Fei Wen
-
依托单位:
海外基金